Finerenone + SGLT2 inhibitors
1 paper1 finding
- 1 lab in 2 countries
- Humans1
Outcomes
1Urinary albumin-to-creatinine ratio
downin humans1
1 study
Urinary albumin-to-creatinine ratio
downin humans1
Finerenone + SGLT2 inhibitors decrease urinary albumin-to-creatinine ratio in humans (-50.6% (95% CI 28.3-65.9%)).
Humansin adults with T2DM-related CKD6 months
Clinical therapeutics8 Sep 2026